The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Classical Swine Fever Vaccines-Global Market Insights and Sales Trends 2025

Classical Swine Fever Vaccines-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1816073

No of Pages : 112

Ask Your Query
Synopsis
It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).
The global Classical Swine Fever Vaccines market size is expected to reach US$ 211 million by 2029, growing at a CAGR of 4.6% from 2023 to 2029. The market is mainly driven by the significant applications of Classical Swine Fever Vaccines in various end use industries. The expanding demands from the Government Tender and Market Sales, are propelling Classical Swine Fever Vaccines market. Tissue Culture Origin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cell Line Origin segment is estimated at % CAGR for the next seven-year period.
The global classical swine fever vaccine market is dominated by Winsun, Boehringer Ingelheim and CAHIC, with the top three manufacturers accounting for about 37% of the market share. Asia Pacific is the largest market for classical swine fever vaccines, with a market share of about 70%, followed by Europe with a market share of about 15%. Tissue Culture Origin is the main type, with a share about 66%. Market Sales is the main application, which holds a share about 95%.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Source, by Sales Channel. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Classical Swine Fever Vaccines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Classical Swine Fever Vaccines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Classical Swine Fever Vaccines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Classical Swine Fever Vaccines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Classical Swine Fever Vaccines covered in this report include WINSUN, Merck, CAHIC, Tecon, SPAH, Boehringer Ingelheim, Ceva, Harbin Veterinary Research Institute and Qilu Animal Health Products Factory, etc.
The global Classical Swine Fever Vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
WINSUN
Merck
CAHIC
Tecon
SPAH
Boehringer Ingelheim
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Global Classical Swine Fever Vaccines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Classical Swine Fever Vaccines market, Segment by Source:
Tissue Culture Origin
Cell Line Origin
Global Classical Swine Fever Vaccines market, by Sales Channel
Government Tender
Market Sales
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Source, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Classical Swine Fever Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Classical Swine Fever Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Sales Channel, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Classical Swine Fever Vaccines Market Overview
1.1 Classical Swine Fever Vaccines Product Overview
1.2 Classical Swine Fever Vaccines Market Segment by Source
1.2.1 Tissue Culture Origin
1.2.2 Cell Line Origin
1.3 Global Classical Swine Fever Vaccines Market Size by Source
1.3.1 Global Classical Swine Fever Vaccines Market Size Overview by Source (2018-2029)
1.3.2 Global Classical Swine Fever Vaccines Historic Market Size Review by Source (2018-2023)
1.3.3 Global Classical Swine Fever Vaccines Forecasted Market Size by Source (2024-2029)
1.4 Key Regions Market Size Segment by Source
1.4.1 North America Classical Swine Fever Vaccines Sales Breakdown by Source (2018-2023)
1.4.2 Europe Classical Swine Fever Vaccines Sales Breakdown by Source (2018-2023)
1.4.3 Asia-Pacific Classical Swine Fever Vaccines Sales Breakdown by Source (2018-2023)
1.4.4 Latin America Classical Swine Fever Vaccines Sales Breakdown by Source (2018-2023)
1.4.5 Middle East and Africa Classical Swine Fever Vaccines Sales Breakdown by Source (2018-2023)
2 Global Classical Swine Fever Vaccines Market Competition by Company
2.1 Global Top Players by Classical Swine Fever Vaccines Sales (2018-2023)
2.2 Global Top Players by Classical Swine Fever Vaccines Revenue (2018-2023)
2.3 Global Top Players by Classical Swine Fever Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Classical Swine Fever Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Classical Swine Fever Vaccines Market Competitive Situation and Trends
2.5.1 Classical Swine Fever Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Classical Swine Fever Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Classical Swine Fever Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Classical Swine Fever Vaccines Market
2.8 Key Manufacturers Classical Swine Fever Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Classical Swine Fever Vaccines Status and Outlook by Region
3.1 Global Classical Swine Fever Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Classical Swine Fever Vaccines Historic Market Size by Region
3.2.1 Global Classical Swine Fever Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Classical Swine Fever Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Classical Swine Fever Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Classical Swine Fever Vaccines Forecasted Market Size by Region
3.3.1 Global Classical Swine Fever Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Classical Swine Fever Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Classical Swine Fever Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Classical Swine Fever Vaccines by Sales Channel
4.1 Classical Swine Fever Vaccines Market Segment by Sales Channel
4.1.1 Government Tender
4.1.2 Market Sales
4.2 Global Classical Swine Fever Vaccines Market Size by Sales Channel
4.2.1 Global Classical Swine Fever Vaccines Market Size Overview by Sales Channel (2018-2029)
4.2.2 Global Classical Swine Fever Vaccines Historic Market Size Review by Sales Channel (2018-2023)
4.2.3 Global Classical Swine Fever Vaccines Forecasted Market Size by Sales Channel (2024-2029)
4.3 Key Regions Market Size Segment by Sales Channel
4.3.1 North America Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2018-2023)
4.3.2 Europe Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2018-2023)
4.3.3 Asia-Pacific Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2018-2023)
4.3.4 Latin America Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2018-2023)
4.3.5 Middle East and Africa Classical Swine Fever Vaccines Sales Breakdown by Sales Channel (2018-2023)
5 North America Classical Swine Fever Vaccines by Country
5.1 North America Classical Swine Fever Vaccines Historic Market Size by Country
5.1.1 North America Classical Swine Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Classical Swine Fever Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Classical Swine Fever Vaccines Sales in Value by Country (2018-2023)
5.2 North America Classical Swine Fever Vaccines Forecasted Market Size by Country
5.2.1 North America Classical Swine Fever Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Classical Swine Fever Vaccines Sales in Value by Country (2024-2029)
6 Europe Classical Swine Fever Vaccines by Country
6.1 Europe Classical Swine Fever Vaccines Historic Market Size by Country
6.1.1 Europe Classical Swine Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Classical Swine Fever Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Classical Swine Fever Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Classical Swine Fever Vaccines Forecasted Market Size by Country
6.2.1 Europe Classical Swine Fever Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Classical Swine Fever Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Classical Swine Fever Vaccines by Region
7.1 Asia-Pacific Classical Swine Fever Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Classical Swine Fever Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Classical Swine Fever Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Classical Swine Fever Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Classical Swine Fever Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Classical Swine Fever Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Classical Swine Fever Vaccines Sales in Value by Region (2024-2029)
8 Latin America Classical Swine Fever Vaccines by Country
8.1 Latin America Classical Swine Fever Vaccines Historic Market Size by Country
8.1.1 Latin America Classical Swine Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Classical Swine Fever Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Classical Swine Fever Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Classical Swine Fever Vaccines Forecasted Market Size by Country
8.2.1 Latin America Classical Swine Fever Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Classical Swine Fever Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Classical Swine Fever Vaccines by Country
9.1 Middle East and Africa Classical Swine Fever Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Classical Swine Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Classical Swine Fever Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Classical Swine Fever Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Classical Swine Fever Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Classical Swine Fever Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Classical Swine Fever Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 WINSUN
10.1.1 WINSUN Company Information
10.1.2 WINSUN Introduction and Business Overview
10.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 WINSUN Classical Swine Fever Vaccines Products Offered
10.1.5 WINSUN Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Classical Swine Fever Vaccines Products Offered
10.2.5 Merck Recent Development
10.3 CAHIC
10.3.1 CAHIC Company Information
10.3.2 CAHIC Introduction and Business Overview
10.3.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 CAHIC Classical Swine Fever Vaccines Products Offered
10.3.5 CAHIC Recent Development
10.4 Tecon
10.4.1 Tecon Company Information
10.4.2 Tecon Introduction and Business Overview
10.4.3 Tecon Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Tecon Classical Swine Fever Vaccines Products Offered
10.4.5 Tecon Recent Development
10.5 SPAH
10.5.1 SPAH Company Information
10.5.2 SPAH Introduction and Business Overview
10.5.3 SPAH Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 SPAH Classical Swine Fever Vaccines Products Offered
10.5.5 SPAH Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Information
10.6.2 Boehringer Ingelheim Introduction and Business Overview
10.6.3 Boehringer Ingelheim Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Boehringer Ingelheim Classical Swine Fever Vaccines Products Offered
10.6.5 Boehringer Ingelheim Recent Development
10.7 Ceva
10.7.1 Ceva Company Information
10.7.2 Ceva Introduction and Business Overview
10.7.3 Ceva Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ceva Classical Swine Fever Vaccines Products Offered
10.7.5 Ceva Recent Development
10.8 Harbin Veterinary Research Institute
10.8.1 Harbin Veterinary Research Institute Company Information
10.8.2 Harbin Veterinary Research Institute Introduction and Business Overview
10.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Products Offered
10.8.5 Harbin Veterinary Research Institute Recent Development
10.9 Qilu Animal Health Products Factory
10.9.1 Qilu Animal Health Products Factory Company Information
10.9.2 Qilu Animal Health Products Factory Introduction and Business Overview
10.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Products Offered
10.9.5 Qilu Animal Health Products Factory Recent Development
10.10 Ringpu Biology
10.10.1 Ringpu Biology Company Information
10.10.2 Ringpu Biology Introduction and Business Overview
10.10.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Ringpu Biology Classical Swine Fever Vaccines Products Offered
10.10.5 Ringpu Biology Recent Development
10.11 DHN
10.11.1 DHN Company Information
10.11.2 DHN Introduction and Business Overview
10.11.3 DHN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.11.4 DHN Classical Swine Fever Vaccines Products Offered
10.11.5 DHN Recent Development
10.12 CAVAC
10.12.1 CAVAC Company Information
10.12.2 CAVAC Introduction and Business Overview
10.12.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.12.4 CAVAC Classical Swine Fever Vaccines Products Offered
10.12.5 CAVAC Recent Development
10.13 Komipharm
10.13.1 Komipharm Company Information
10.13.2 Komipharm Introduction and Business Overview
10.13.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Komipharm Classical Swine Fever Vaccines Products Offered
10.13.5 Komipharm Recent Development
10.14 Agrovet
10.14.1 Agrovet Company Information
10.14.2 Agrovet Introduction and Business Overview
10.14.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Agrovet Classical Swine Fever Vaccines Products Offered
10.14.5 Agrovet Recent Development
10.15 Bioveta
10.15.1 Bioveta Company Information
10.15.2 Bioveta Introduction and Business Overview
10.15.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Bioveta Classical Swine Fever Vaccines Products Offered
10.15.5 Bioveta Recent Development
10.16 Jinyu Bio-Technology
10.16.1 Jinyu Bio-Technology Company Information
10.16.2 Jinyu Bio-Technology Introduction and Business Overview
10.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Products Offered
10.16.5 Jinyu Bio-Technology Recent Development
10.17 Institutul Pasteur
10.17.1 Institutul Pasteur Company Information
10.17.2 Institutul Pasteur Introduction and Business Overview
10.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Institutul Pasteur Classical Swine Fever Vaccines Products Offered
10.17.5 Institutul Pasteur Recent Development
10.18 MVP
10.18.1 MVP Company Information
10.18.2 MVP Introduction and Business Overview
10.18.3 MVP Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.18.4 MVP Classical Swine Fever Vaccines Products Offered
10.18.5 MVP Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Classical Swine Fever Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Classical Swine Fever Vaccines Industrial Chain Analysis
11.4 Classical Swine Fever Vaccines Market Dynamics
11.4.1 Classical Swine Fever Vaccines Industry Trends
11.4.2 Classical Swine Fever Vaccines Market Drivers
11.4.3 Classical Swine Fever Vaccines Market Challenges
11.4.4 Classical Swine Fever Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Classical Swine Fever Vaccines Distributors
12.3 Classical Swine Fever Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock